SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $22,000 | -4.3% | 300 | 0.0% | 0.01% | +14.3% |
Q1 2022 | $23,000 | -14.8% | 300 | 0.0% | 0.01% | -12.5% |
Q4 2021 | $27,000 | -3.6% | 300 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $28,000 | +21.7% | 300 | 0.0% | 0.01% | +14.3% |
Q2 2021 | $23,000 | +4.5% | 300 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $22,000 | -56.9% | 300 | 0.0% | 0.01% | -58.8% |
Q4 2020 | $51,000 | +21.4% | 300 | 0.0% | 0.02% | +6.2% |
Q3 2020 | $42,000 | -12.5% | 300 | 0.0% | 0.02% | -20.0% |
Q2 2020 | $48,000 | +65.5% | 300 | 0.0% | 0.02% | +33.3% |
Q1 2020 | $29,000 | -23.7% | 300 | 0.0% | 0.02% | -11.8% |
Q4 2019 | $38,000 | +65.2% | 300 | 0.0% | 0.02% | +41.7% |
Q3 2019 | $23,000 | -50.0% | 300 | 0.0% | 0.01% | -50.0% |
Q2 2019 | $46,000 | -23.3% | 300 | -40.0% | 0.02% | -22.6% |
Q1 2019 | $60,000 | +11.1% | 500 | 0.0% | 0.03% | -3.1% |
Q4 2018 | $54,000 | -33.3% | 500 | 0.0% | 0.03% | -25.6% |
Q3 2018 | $81,000 | – | 500 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,999,453 | $413,414,607 | 13.31% |
Casdin Capital, LLC | 1,160,000 | $159,882,800 | 13.17% |
Ikarian Capital, LLC | 271,300 | $37,393,279 | 8.48% |
Avoro Capital Advisors LLC | 3,650,000 | $503,079,500 | 7.46% |
Evolutionary Tree Capital Management, LLC | 36,190 | $4,988,068 | 6.91% |
Finepoint Capital LP | 122,757 | $16,919,597 | 6.46% |
Ikarian Capital, LLC | 205,400 | $28,310,282 | 6.42% |
Boxer Capital, LLC | 775,000 | $106,818 | 5.25% |
Ghost Tree Capital, LLC | 125,000 | $17,229,000 | 5.09% |
Logos Global Management LP | 220,000 | $30,322,600 | 4.34% |